Upcoming Webinars

https://biopharmawebinars.com/webinars/analytical-assessment-of-leachables-in-biological-drug-products-fda-approach-in-reviewing-information/

Analytical Assessment of Leachables in Biological Drug Products: FDA Approach in Reviewing Information

Presented by Andrey Sarafanov; PhD., Principal Investigator at U.S. FDA, Center for Biologics Evaluation and Research, Molly Haan, Senior Technical Customer Support Scientist at NAMSA , James Hathcock, Sr. Director, Regulatory and Validation Strategy at Cytiva
02nd October 2025

Just in Time Release of CAR T Cell Therapies

Presented by Irving Ford, VP of Quality at Adaptimmune, Owen Griffin, Senior Director, Microbiology at Rapid Micro Biosystems
03rd October 2025

Effective Extractable & Leachable Study Design

Presented by Divya Regulagedda, Manager, Global SME- Extractables & Leachables at Chemo
08th October 2025

Oncolytic Virus GMP Manufacturing: Solving Antibody Neutralization Challenges with Next Generation Sequencing

Presented by Colette Côté, PhD, U.S. General Manager and Chief Scientific and Portfolio Officer at PathoQuest
21st October 2025

On Demand Webinars

https://biopharmawebinars.com/webinars/consideration-how-to-use-retention-index-information-e-g-nist23-to-support-mass-spectral-matching-msm-based-identifications-in-gc-ms/

Consideration how to use Retention Index information (e.g., NIST23) to support Mass Spectral Matching (MSM) based identifications in GC/MS

Presented by Presented by Piet Christiaens, Scientific Director at Nelson Labs and Philippe Verlinde, Technical Advisor at Nelson Labs
30th September 2025

https://biopharmawebinars.com/webinars/vaccine-development-its-manufacturing-using-integrated-high-throughput-technology-2/